🟢 Citius Pharmaceuticals is trading 5.72% up today after preliminary LYMPHIR shipments rose 120% sequentially

Citius Pharmaceuticals is trading at $0.53, up 5.72%, with the LYMPHIR shipment update the clearest company-specific context.

• Citius Oncology’s October 26 report said wholesaler shipments rose 120% sequentially to 792 units, alongside 54 institutions ordering LYMPHIR; the figures are preliminary and unaudited.
• The stock has advanced across several sessions; no separate October 28 company announcement surfaced in the search. Broader indices were modestly higher, and no trading-volume figure was provided for the live move.